» Articles » PMID: 20459693

Effects of Perfluorocarbons on Surfactant Exocytosis and Membrane Properties in Isolated Alveolar Type II Cells

Overview
Journal Respir Res
Specialty Pulmonary Medicine
Date 2010 May 13
PMID 20459693
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Perfluorocarbons (PFC) are used to improve gas exchange in diseased lungs. PFC have been shown to affect various cell types. Thus, effects on alveolar type II (ATII) cells and surfactant metabolism can be expected, data, however, are controversial.

Objective: The study was performed to test two hypotheses: (I) the effects of PFC on surfactant exocytosis depend on their respective vapor pressures; (II) different pathways of surfactant exocytosis are affected differently by PFC.

Methods: Isolated ATII cells were exposed to two PFC with different vapor pressures and spontaneous surfactant exocytosis was measured. Furthermore, surfactant exocytosis was stimulated by either ATP, PMA or ionomycin. The effects of PFC on cell morphology, cellular viability, endocytosis, membrane permeability and fluidity were determined.

Results: The spontaneous exocytosis was reduced by PFC, however, the ATP and PMA stimulated exocytosis was slightly increased by PFC with high vapor pressure. In contrast, Ionomycin-induced exocytosis was decreased by PFC with low vapor pressure. Cellular uptake of FM 1-43 - a marker of membrane integrity - was increased. However, membrane fluidity, endocytosis and viability were not affected by PFC incubation.

Conclusions: We conclude that PFC effects can be explained by modest, unspecific interactions with the plasma membrane rather than by specific interactions with intracellular targets.

Citing Articles

Pulmonary surfactant preserves viability of alveolar type II cells exposed to polymyxin B in vitro.

Stichtenoth G, Herting E, Rudiger M, Wemhoner A PLoS One. 2013; 8(4):e62105.

PMID: 23620808 PMC: 3631157. DOI: 10.1371/journal.pone.0062105.


Persurf, a new method to improve surfactant delivery: a study in surfactant depleted rats.

Burkhardt W, Kraft S, Ochs M, Proquitte H, Mense L, Rudiger M PLoS One. 2012; 7(10):e47923.

PMID: 23082229 PMC: 3474734. DOI: 10.1371/journal.pone.0047923.


Perfluorochemical liquid-adenovirus suspensions enhance gene delivery to the distal lung.

Kazzaz J, Strayer M, Wu J, Malone D, Koo H, Shaffer T Pulm Med. 2011; 2011:918036.

PMID: 21876799 PMC: 3159382. DOI: 10.1155/2011/918036.

References
1.
Burkhardt W, Koehne P, Wissel H, Graf S, Proquitte H, Wauer R . Intratracheal perfluorocarbons diminish LPS-induced increase in systemic TNF-alpha. Am J Physiol Lung Cell Mol Physiol. 2008; 294(6):L1043-8. DOI: 10.1152/ajplung.00125.2007. View

2.
van Eeden S, Klut M, Leal M, Alexander J, Zonis Z, Skippen P . Partial liquid ventilation with perfluorocarbon in acute lung injury: light and transmission electron microscopy studies. Am J Respir Cell Mol Biol. 2000; 22(4):441-50. DOI: 10.1165/ajrcmb.22.4.3717. View

3.
Leach C, Greenspan J, Rubenstein S, Shaffer T, Wolfson M, Jackson J . Partial liquid ventilation with perflubron in premature infants with severe respiratory distress syndrome. The LiquiVent Study Group. N Engl J Med. 1996; 335(11):761-7. DOI: 10.1056/NEJM199609123351101. View

4.
Kubina M, Lanza F, Cazenave J, LAUSTRIAT G, Kuhry J . Parallel investigation of exocytosis kinetics and membrane fluidity changes in human platelets with the fluorescent probe, trimethylammonio-diphenylhexatriene. Biochim Biophys Acta. 1987; 901(1):138-46. DOI: 10.1016/0005-2736(87)90265-3. View

5.
Rooney S . Regulation of surfactant secretion. Comp Biochem Physiol A Mol Integr Physiol. 2001; 129(1):233-43. DOI: 10.1016/s1095-6433(01)00320-8. View